These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 4977403)

  • 1. A double blind study of clomacran.
    Lampe WT
    Curr Ther Res Clin Exp; 1969 May; 11(5):300-6. PubMed ID: 4977403
    [No Abstract]   [Full Text] [Related]  

  • 2. A transcultural study with clomacran: comparison of two assessment methods.
    Ban TA; Lehmann HE; Galvan L; Pecknold JC; Climan M
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):971-89. PubMed ID: 4214672
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Clomacran in the treatment of schizophrenic patients--a comparison of two assessment methods.
    Galvan L; Torres A; Nieto D
    Psychopharmacol Bull; 1976 Jan; 12(1):30-1. PubMed ID: 1108081
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled comparison of SK&F 14336 and chlorpromazine in newly admitted schizophrenics.
    Overall JE; Hollister LE; Prusmack JJ; Shelton J; Pokorny A
    J Clin Pharmacol J New Drugs; 1969; 9(5):328-38. PubMed ID: 4899114
    [No Abstract]   [Full Text] [Related]  

  • 5. Clomacran and chlorpromazine in psychotic outpatients: a controlled study.
    Case WG; Ryder BL; Dhopeshwarkar VP; Pereira-Ogan JA; Rickels K
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):337-43. PubMed ID: 4996219
    [No Abstract]   [Full Text] [Related]  

  • 6. Clomacran in the treatment of schizophrenic patients: a comparison of two assessment methods.
    Pecknold JC; Ban TA; Lehmann HE; Climan M
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):299-303. PubMed ID: 1099021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 9. Double blind study of an acridan derivative (SK & F 14336) versus chlorpromazine.
    Chen CP; Tsuang MM
    Curr Ther Res Clin Exp; 1968 May; 10(5):223-30. PubMed ID: 4967734
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
    Shopsin B; Pearson E; Gershon S; Collins P
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Winter K; Fullerton AG; Hussain K; Tarlo L
    Br J Clin Pract; 1973 Oct; 27(10):377-80. PubMed ID: 4601614
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative trial of oxypertine and chlorpromazine in the treatment of acute psychoses.
    Wadzisz FJ
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):784-92. PubMed ID: 4984044
    [No Abstract]   [Full Text] [Related]  

  • 14. The behavioral pharmacology of oxypertine.
    Claghorn J; Schoolar JC
    J Clin Pharmacol J New Drugs; 1970; 10(3):203-6. PubMed ID: 4910277
    [No Abstract]   [Full Text] [Related]  

  • 15. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial of clomacran phosphate (SKF-14336) in chronic psychotic male patients.
    Nair KC; Chen CH
    Curr Ther Res Clin Exp; 1970 Jun; 12(6):394-401. PubMed ID: 4987347
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
    Gendron JL; Zimmermann RL; Schiele BC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):333-6. PubMed ID: 4197258
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxypertine in the treatment of schizophrenia.
    Alapin B; Golebiewska M
    Act Nerv Super (Praha); 1967 Nov; 9(4):436-9. PubMed ID: 4889080
    [No Abstract]   [Full Text] [Related]  

  • 19. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
    Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.